Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription


2 Mol Psychiatry
2 Psychiatry Res
1 Psychol Med
1 Schizophr Res

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Mol Psychiatry

  1. MERIKANGAS AK, Almasy L
    Reply to "Comment on: What genes are differentially expressed in individuals with schizophrenia? A systematic review".
    Mol Psychiatry. 2022 Oct 12. pii: 10.1038/s41380-022-01821.

  2. BOYER L, Fond G, Pauly V, Orleans V, et al
    Impact of the COVID-19 pandemic on non-COVID-19 hospital mortality in patients with schizophrenia: a nationwide population-based cohort study.
    Mol Psychiatry. 2022 Oct 7. pii: 10.1038/s41380-022-01803.
    PubMed         Abstract available

    Psychiatry Res

  3. MORITZ S, Goritz AS, Franz C, Sibilis A, et al
    Whodunit - A novel video-based task for the measurement of jumping to conclusions in the schizophrenia spectrum.
    Psychiatry Res. 2022;317:114862.
    PubMed         Abstract available

  4. PELIZZA L, Quattrone E, Leuci E, Paulillo G, et al
    Anxious-depressive symptoms after a first episode of schizophrenia: Response to treatment and psychopathological considerations from the 2-year "Parma Early Psychosis" program.
    Psychiatry Res. 2022;317:114887.
    PubMed         Abstract available

    Psychol Med

  5. ANTONUCCI LA, Pergola G, Rampino A, Rocca P, et al
    Clinical and psychological factors associated with resilience in patients with schizophrenia: data from the Italian network for research on psychoses using machine learning.
    Psychol Med. 2022 Oct 11:1-12. doi: 10.1017/S003329172200294.
    PubMed         Abstract available

    Schizophr Res

  6. NAGENDRA A, Orleans-Pobee M, Vincent C, Padgett J, et al
    The representation of authors of color in schizophrenia research articles published in high-impact psychiatric journals.
    Schizophr Res. 2022 Oct 7. pii: S0920-9964(22)00323.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.